Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1-carboxylate, compositions and methods of use thereof

MYPI2025005263A0Undetermined Publication Date: 2020-03-13LUNDBECK LA JOLLA RESEARCH CENTER INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005263
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-09-12
Filing Date
2019-09-12
Publication Date
2020-03-13
Patent Text Reader

Abstract

Provided herein are crystalline forms of (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate. Pharmaceutical compositions comprising crystalline forms of (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piper azine-1-carboxylate are also disclosed.
Need to check novelty before this filing date? Find Prior Art